Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05686928 · ClinicalTrials.gov registry record · Phase 4
Healing Ointment Usage Post-surgical Procedure
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT05686928 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 15 participants.
The verdict
NCT05686928, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
To evaluate benefits of a Healing Ointment in skin improvement after dermatologic procedures
Interventions
- DRUG Cetaphil Healing Ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-08-17 |
| Est. Completion | 2022-11-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05686928
The ClinicalTrials.gov registry entry for NCT05686928 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cetaphil Healing Ointment is the first listed.
NCT05686928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05686928 about?
NCT05686928 is a clinical study titled "Healing Ointment Usage Post-surgical Procedure". To evaluate benefits of a Healing Ointment in skin improvement after dermatologic procedures
What is the current status of trial NCT05686928?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2022-08-17. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT05686928?
The interventions under investigation include: Cetaphil Healing Ointment (DRUG).
Who is sponsoring clinical trial NCT05686928?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.